Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis


Por: Segura, AG, Verdolini, N, Valli, I, Garcia-Rizo, C, Diaz-Caneja, CM, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldan, A, Martinez-Aran, A, Baeza, I, Mane, A, Labad, J, Müller, DJ, Guasch-Capella, N, Bernardo, M, Mas, S, Bioque, GM, Gonzalez, J, Andrés, P, Cavone, V, Corripio, I, Duque, A, Mar-Barrutia, L, Marin, J, De-la-Camara, C, Vaquero-Puyuelo, D, Rivero, O, Fabra, MJE, Trabsa, A, Legido, T, Forte, MF, Serra-Navarro, M, de la Serna, H, Castro-Fornielles, J, Contreras, F, García-Portilla, MP, González-Blanco, L, Echevarría, RS, Rabadán, AZ, Rodriguez-Jimenez, R, Martínez-Gras, I, Usall, J, Barajas, A, Sarro, S, Pomarol-Clotet, E, Ibañez, A and Cuesta, MJ

Publicada: 1 nov 2025 Ahead of Print: 1 oct 2025
Resumen:
Objective: First episode of psychosis (FEP) is associated with glucose homeostasis abnormalities even before pharmacological intervention. Given inconclusive GWAS results regarding a direct genetic link between schizophrenia and type 2 diabetes mellitus (T2DM), we hypothesized that FEP patients may exhibit altered genetic risk for glycemic traits. We compared polygenic risk scores (PRS) for T2DM (PRST2DM), fasting glucose (PRSFG), and glycated hemoglobin (HbA1c) (PRSHbA1c) between FEP patients and controls, examining their associations with glycemic measures over 24 months. Methods: We analyzed data from 242 FEP patients and 119 controls, assessing fasting serum glucose and HbA1c at baseline and 24 months. We examined cross-sectional and longitudinal associations between PRS and glycemic measures within each group. Results: FEP patients and controls did not differ significantly in PRS. Significant associations were observed for PRSFG with baseline serum glucose in controls (p = 0.008), PRSFG during follow-up (p = 0.034), PRSHbA1c at 24 months (p = 0.018), and HbA1c longitudinally (p = 0.025). After multiple testing corrections, only the association between PRSFG and baseline serum glucose in controls remained significant (p_adj = 0.023). No associations were found for PRST2DM. Conclusions: Despite the link between FEP and glycemic disturbances, PRST2DM did not differ between FEP patients and controls. However, PRS for glycemic traits showed associations with glycemic measures in both groups before multiple testing correction, suggesting that genetic predisposition may influence glucose homeostasis in early psychosis. The absence of a direct association between common genetic variants underlying T2DM and early glycemic dysregulation in FEP underscores the importance of considering environmental factors and epigenetic mechanisms.

Filiaciones:
Segura, AG:
 Hosp Clin Barcelona, Bipolar & Depress Disorders Unit, Barcelona, Spain

Verdolini, N:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Umbria 1 Mental Hlth Ctr, Dept Mental Hlth, Perugia, Italy

Valli, I:
 Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England

Garcia-Rizo, C:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit BCSU, Barcelona Clin, Barcelona, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

Diaz-Caneja, CM:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Complutense, Inst Psychiat & Mental Hlth, Dept Child & Adolescent Psychiat, Sch Med,Hosp Gen Univ Gregorio Maranon,IiSGM, Madrid, Spain

 Univ Zaragoza, Dept Med & Psychiat, Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza, Spain

Vieta, E:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Pharmacol Unit, Barcelona, Spain

Lobo, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Zaragoza, Dept Med & Psychiat, Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza, Spain

Gonzalez-Pinto, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Univ Alava, Dept Psychiat, UPV EHU, BIOARABA, Vitoria, Spain

Andreu-Bernabeu, A:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

Roldan, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Dept Psychiat, Barcelona, Spain

Martinez-Aran, A:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Pharmacol Unit, Barcelona, Spain

Baeza, I:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain

Mane, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Pompeu Fabra Univ, Hosp del Mar, Med Res Inst IMIM, Barcelona, Spain

:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Mataro, Consorci Sanitari Maresme, Fundacio Parc Tauli, Mataro, Catalonia, Spain

 Univ Autonoma Barcelona UAB, Inst Innovac & Invest Parc Tauli I3PT, Inst Neurociencies, Translat Neurosci Res Unit I3PT Inc UAB, Bellaterra, Spain

Müller, DJ:
 Univ Toronto, Dept Psychiat, Toronto, ON, Canada

 Ctr Addict & Mental Hlth, Toronto, ON, Canada

Guasch-Capella, N:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit BCSU, Barcelona Clin, Barcelona, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

Bernardo, M:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit BCSU, Barcelona Clin, Barcelona, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

Mas, S:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, Pharmacol Unit, Barcelona, Spain

Bioque, GM:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Clin Barcelona, Neurosci Inst, Schizophrenia Unit BCSU, Barcelona Clin, Barcelona, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

Gonzalez, J:
 Univ Rosario, Sch Med & Hlth Sci, UR Ctr Mental Hlth CERSAME, Bogota, Colombia

 Clin Nuestra Senora de la Paz, Bogota, Colombia

Andrés, P:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Complutense, Inst Psychiat & Mental Hlth, Dept Child & Adolescent Psychiat, Sch Med,Hosp Gen Univ Gregorio Maranon,IiSGM, Madrid, Spain

Cavone, V:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Univ Complutense, Inst Psychiat & Mental Hlth, Dept Child & Adolescent Psychiat, Sch Med,Hosp Gen Univ Gregorio Maranon,IiSGM, Madrid, Spain

Corripio, I:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Dept Psychiat, Barcelona, Spain

Duque, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Dept Psychiat, Barcelona, Spain

Mar-Barrutia, L:
 Hosp Univ Alava, Dept Psychiat, UPV EHU, BIOARABA, Vitoria, Spain

Marin, J:
 Hosp Univ Alava, Dept Psychiat, UPV EHU, BIOARABA, Vitoria, Spain

Vaquero-Puyuelo, D:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Zaragoza, Dept Med & Psychiat, Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza, Spain

Rivero, O:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Valencia, Dept Genet, Campus Burjassot, Valencia, Spain

 Fdn Invest Hosp Clin Valencia, Biomed Res Inst INCLIVA, Valencia, Spain

Fabra, MJE:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Fdn Invest Hosp Clin Valencia, Biomed Res Inst INCLIVA, Valencia, Spain

 Univ Oviedo, Dept Psychiat,Inst Univ Neurociencias Principado A, Serv Salud Principado Asturias SESPA Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain

Trabsa, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Pompeu Fabra Univ, Hosp del Mar, Med Res Inst IMIM, Barcelona, Spain

Legido, T:
 Pompeu Fabra Univ, Hosp del Mar, Med Res Inst IMIM, Barcelona, Spain

Forte, MF:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Dept Clin Fdn, Pharmacol Unit, Barcelona, Spain

Serra-Navarro, M:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Dept Clin Fdn, Pharmacol Unit, Barcelona, Spain

de la Serna, H:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain

Castro-Fornielles, J:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Barcelona, Med Dept, Barcelona, Spain

 Hosp Clin Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain

Contreras, F:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Bellvitge Univ, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Lhospitalet De Llobregat, Spain

García-Portilla, MP:
 Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain

 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

González-Blanco, L:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Oviedo, Dept Psychiat,Inst Univ Neurociencias Principado A, Serv Salud Principado Asturias SESPA Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain

Echevarría, RS:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Hosp Clin Univ Valencia, Dept Psychiat, Valencia, Spain

 Univ Basque Country UPV EHU Vizcaya, Cruces Univ Hosp, BioCruces Hlth Res Inst, Bilbao, Spain

Rabadán, AZ:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Basque Country UPV EHU, BioCruces Hlth Res Inst, Dept Neurosci, Vizcaya, Spain

Rodriguez-Jimenez, R:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Complutense Madrid UCM, Inst Invest Sanitaria Hosp 12 Octubre imas12, Madrid, Spain

Martínez-Gras, I:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Inst Hlth Carlos III, RETIC Network Addict Condit, Inst Invest Sanitaria Hosp 12 Octubre imas12, Madrid, Spain

Usall, J:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Inst Recerca St Joan de Deu, Esplugas de Llobregat, Parc Sanitari S, Spain

Barajas, A:
 Inst Recerca St Joan de Deu, Esplugas de Llobregat, Spain

 Hosp Materno Infantil St Joan de Deu, Esplugas de Llobregat, Spain

Sarro, S:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 FIDMAG Germanes Hosp Res Fdn, St Boi De Llobregat, Barcelona, Spain

Pomarol-Clotet, E:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 FIDMAG Germanes Hosp Res Fdn, St Boi De Llobregat, Barcelona, Spain

Ibañez, A:
 Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain

 Univ Alcala, Hosp Univ Ramon Y Cajal, Dept Psychiat, Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Madrid, Spain

Cuesta, MJ:
 Hosp Univ Navarra, Dept Psychiat, Inst Invest Sanitaria Navarra IdiSNa, Pamplona, Spain
ISSN: 09209964





Schizophrenia Research
Editorial
Elsevier BV, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 285 Número:
Páginas: 265-275
WOS Id: 001595580300001
ID de PubMed: 41075679
imagen Green Submitted

MÉTRICAS